Indeks Rilis Pers English

Chinese Publishing Industry Showcases Global Vision and Forges Deeper Ties at 2026 London Book Fair
PR Newswire
Jumat, 20 Mar

Chinese Publishing Industry Showcases Global Vision and Forges Deeper Ties at 2026 London Book Fair

2026 Yili Online Tour Kick-off: Global Recruitment for "Yili Quality Ambassadors" Now Open!
PR Newswire
Jumat, 20 Mar

2026 Yili Online Tour Kick-off: Global Recruitment for "Yili Quality Ambassadors" Now Open!

Yes, There's Now a Harvard-Inspired Phone Case -- and It's Surprisingly Refined
PR Newswire
Jumat, 20 Mar

Yes, There's Now a Harvard-Inspired Phone Case -- and It's Surprisingly Refined

Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs
PR Newswire
Jumat, 20 Mar

Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs

Forbes China Recognizes Fox ESS as a 2026 Leading Enterprise in Renewable Energy
PR Newswire
Jumat, 20 Mar

Forbes China Recognizes Fox ESS as a 2026 Leading Enterprise in Renewable Energy

Decoding TOPCon: A JA Solar-University of New South Wales Dialogue on the Future of PV
PR Newswire
Jumat, 20 Mar

Decoding TOPCon: A JA Solar-University of New South Wales Dialogue on the Future of PV

Arcfra AECP 6.3 Breaks the 11M IOPS Barrier, Delivering Tier-1 All-Flash Performance and RPO=0 Resilience for Enterprise Cloud
PR Newswire
Jumat, 20 Mar

Arcfra AECP 6.3 Breaks the 11M IOPS Barrier, Delivering Tier-1 All-Flash Performance and RPO=0 Resilience for Enterprise Cloud

Dematic Redefines Warehouse Intelligence with Launch of Command Center
PR Newswire
Jumat, 20 Mar

Dematic Redefines Warehouse Intelligence with Launch of Command Center

Taiwan Showcases "100 Ways" to Explore the Destination at NATAS Travel Fair 2026
PR Newswire
Jumat, 20 Mar

Taiwan Showcases "100 Ways" to Explore the Destination at NATAS Travel Fair 2026

Agoda's Top Picks for Unique Zipline Adventures in Asia
PR Newswire
Jumat, 20 Mar

Agoda's Top Picks for Unique Zipline Adventures in Asia

Professor Chun-Hung Chu: "Protecting Oral Health Is Protecting Quality of Life"
PR Newswire
Jumat, 20 Mar

Professor Chun-Hung Chu: "Protecting Oral Health Is Protecting Quality of Life"

Redefining the Future of Financial Advisory Firms in Singapore at the MDRT CEO Forum
PR Newswire
Jumat, 20 Mar

Redefining the Future of Financial Advisory Firms in Singapore at the MDRT CEO Forum

iQIYI's "Pursuit of Jade" Captures Global Audience with Chart-Topping Performance
PR Newswire
Jumat, 20 Mar

iQIYI's "Pursuit of Jade" Captures Global Audience with Chart-Topping Performance

Circles and Huawei Sign Strategic Collaboration to Advance AI-Native Digital Telecom Solutions Globally
PR Newswire
Jumat, 20 Mar

Circles and Huawei Sign Strategic Collaboration to Advance AI-Native Digital Telecom Solutions Globally

China's 'open-source' modernization offers inspiration for global development, says expert
PR Newswire
Jumat, 20 Mar

China's 'open-source' modernization offers inspiration for global development, says expert

Hong Kong Startup Comfiknit Shares Breakthrough Technology at the MIT Sports Summit
PR Newswire
Jumat, 20 Mar

Hong Kong Startup Comfiknit Shares Breakthrough Technology at the MIT Sports Summit

MGI Tech and NUS Pharmacy and Pharmaceutical Sciences Announce Collaboration on DCS Lab to Accelerate Multi-Omics Innovation in Pharmaceutical Sciences
PR Newswire
Jumat, 20 Mar

MGI Tech and NUS Pharmacy and Pharmaceutical Sciences Announce Collaboration on DCS Lab to Accelerate Multi-Omics Innovation in Pharmaceutical Sciences

/C O R R E C T I O N -- Nanoverse Technologies, Limited/
PR Newswire
Jumat, 20 Mar

/C O R R E C T I O N -- Nanoverse Technologies, Limited/

From Volcanoes to No-Man's Land, Infinix NOTE 60 SERIES Is Built for Every Extreme
PR Newswire
Jumat, 20 Mar

From Volcanoes to No-Man's Land, Infinix NOTE 60 SERIES Is Built for Every Extreme

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016
PR Newswire
Jumat, 20 Mar

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Triple-Negative Breast Cancer of TROP2/HER3 Bispecific ADC JSKN016